Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.59%12.63B | 18.29%49.82B | 27.24%12.08B | -1.42%42.11B | 22.62%11.25B | 3.93%10.96B | -10.89%10.4B | -16.14%9.49B | -0.85%42.72B | -11.96%9.18B |
| Cost of revenue | 7.53%10.01B | 9.88%38.19B | 11.73%9.31B | -0.44%34.76B | 13.62%8.89B | 0.84%8.87B | -4.55%8.66B | -9.56%8.33B | 1.43%34.91B | -8.77%7.83B |
| Gross profit | -5.28%2.62B | 58.01%11.62B | 138.59%2.77B | -5.82%7.35B | 74.67%2.36B | 19.41%2.1B | -33.09%1.74B | -44.90%1.16B | -9.90%7.81B | -26.77%1.35B |
| Operating expense | 1.19%1.72B | 14.60%6.73B | 20.68%1.7B | 5.20%5.87B | 21.02%1.53B | 9.30%1.62B | -8.36%1.32B | 0.56%1.41B | 4.38%5.58B | -5.07%1.26B |
| Staff costs | ---- | 17.81%2.48B | ---- | 2.89%2.11B | ---- | ---- | ---- | ---- | -0.55%2.05B | ---- |
| Selling and administrative expenses | ---- | 19.89%1.03B | ---- | 13.30%859.08M | ---- | ---- | ---- | ---- | -2.40%758.2M | ---- |
| -General and administrative expense | ---- | 19.89%1.03B | ---- | 13.30%859.08M | ---- | ---- | ---- | ---- | -2.40%758.2M | ---- |
| Other operating expenses | ---- | 10.70%3.21B | ---- | 4.69%2.9B | ---- | ---- | ---- | ---- | 10.54%2.77B | ---- |
| Operating profit | -15.58%902.97M | 229.78%4.89B | 531.68%1.07B | -33.41%1.48B | 818.09%835.59M | 73.78%478.38M | -63.88%417.59M | -135.10%-247.77M | -32.91%2.23B | -82.43%91.01M |
| Net non-operating interest income (expenses) | -38.72%-35.13M | -18.38%-101.33M | -10.27%-25.33M | -545.11%-85.6M | -113.78%-20.36M | -79.10%-26.24M | -3,297.25%-16.04M | -301.89%-22.97M | -120.16%-13.27M | -177.79%-9.53M |
| Non-operating interest income | -56.23%9.23M | -23.63%89.22M | 3.27%21.09M | -17.61%116.83M | -7.56%35.91M | 2.46%27.52M | -3.45%32.98M | -51.30%20.42M | -23.99%141.8M | -12.60%38.85M |
| Non-operating interest expense | -4.42%44.36M | -5.87%190.56M | 6.98%46.41M | 30.55%202.43M | 16.33%56.28M | 29.51%53.75M | 41.53%49.02M | 42.00%43.39M | 28.45%155.07M | 50.19%48.37M |
| Net investment income | -75.70%50.1M | 232.83%267.24M | 91.49%206.17M | -70.70%80.29M | 36.32%-83.91M | 206.51%64.18M | -116.22%-7.65M | -74.30%107.67M | -47.28%273.99M | -137.19%-131.77M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 70.01M | -99.63%2.5M | 0 | -47.98%679.04M | 574,950.00%23M | -94.46%28.1M | 67.88%1.31B | -99.99%4K | ||
| Income from associates and other participating interests | 0 | 0 | -337.79%-47.18M | -99.99%2K | -4.15M | -14.47M | -28.56M | 29.31%19.84M | 19.84M | |
| Special income (charges) | -146.77%-802K | 92.81%-6.84M | 98.80%-325K | 20.89%-95.11M | -307.51%-69.51M | -827.51%-662.32M | 3,526.33%663.91M | 45.69%-27.19M | -637.74%-120.22M | 37.03%-17.06M |
| Less:Other special charges | 131.71%802K | -102.98%-2.37M | -110.53%-2.53M | -21.11%79.59M | 486.37%62.53M | 839.53%660.33M | -2,115.34%-667.28M | -52.04%24.01M | 2,895.55%100.89M | -24.69%10.66M |
| Less:Write off | --0 | -40.68%9.21M | -10.28%2.85M | -19.70%15.52M | 9.21%6.98M | 76.36%1.98M | -71.42%3.38M | --3.18M | 49.54%19.33M | -50.54%6.39M |
| Other non-operating income (expenses) | -41.61%54.89M | 264.33%208.61M | 396.70%94M | -72.58%57.26M | -8.21%38.98M | -112.80%-12.32M | -59.57%11.67M | -54.12%18.92M | -26.11%208.82M | -71.50%42.47M |
| Income before tax | -22.47%1.04B | 153.96%5.26B | 882.37%1.34B | -46.89%2.07B | 14,523.93%723.79M | 119.17%493.57M | -49.86%1.03B | -110.51%-171.8M | -21.41%3.9B | -100.47%-5.02M |
| Income tax | -15.89%313.85M | 198.98%1.29B | 1,143.37%373.12M | -58.54%432.71M | 132.83%65.72M | -40.89%75.32M | -59.86%261.67M | -93.54%30.01M | 8.54%1.04B | -263.78%-200.19M |
| Net income | -25.00%728.19M | 142.09%3.97B | 581.14%970.97M | -42.64%1.64B | 237.17%658.07M | 327.74%418.26M | -45.19%765.25M | -117.25%-201.81M | -28.60%2.86B | -79.31%195.18M |
| Net income continuous operations | -25.00%728.19M | 142.09%3.97B | 581.14%970.97M | -42.64%1.64B | 237.17%658.07M | 327.74%418.26M | -45.19%765.25M | -117.25%-201.81M | -28.60%2.86B | -79.31%195.18M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -97.36%2.47M | 0 |
| Net income attributable to the company | -25.00%728.19M | 142.09%3.97B | 581.14%970.97M | -42.59%1.64B | 237.17%658.07M | 327.74%418.26M | -45.19%765.25M | -117.29%-201.81M | -26.96%2.86B | -79.23%195.17M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -25.00%728.19M | 142.09%3.97B | 581.14%970.97M | -42.59%1.64B | 237.17%658.07M | 327.74%418.26M | -45.19%765.25M | -117.29%-201.81M | -26.96%2.86B | -79.23%195.17M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -25.14%21.92 | 141.35%119.49 | 580.00%29.28 | -42.74%49.51 | 234.51%19.87 | 300.63%12.62 | -45.29%23.12 | -117.37%-6.1 | -26.35%86.46 | -78.95%5.94 |
| Diluted earnings per share | -25.04%21.91 | 141.39%119.39 | 579.18%29.23 | -42.65%49.46 | 235.70%19.84 | 307.10%12.62 | -45.15%23.12 | -117.39%-6.1 | -26.49%86.24 | -79.04%5.91 |
| Dividend per share | 0 | 60.00%96 | 0 | -33.33%60 | -55.56%40 | 0 | 20 | 0 | 0.00%90 | 0.00%90 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |